Cancer Biology & Medicine Open Access Editor-in-Chief: Xishan Hao
Volume 23 Issue 1, January 2026
PP. 1-153
|
11 articles
|
Next Issue
EDITORIAL
Editorial | Open Access
Cancer stem cells in hepatocellular carcinoma: platforms, updates, challenges and future perspectives
Published: 16 December 2025
2026, 23(1): 1-7
Editorial | Open Access
Introduction and impact of the young breast cancer in China consensus
Published: 19 December 2025
2026, 23(1): 8-14
PERSPECTIVE
Perspective | Open Access
Rethinking anti-cancer drug discovery: the evolution from polypharmacy to unified drug units
Published: 29 January 2026
2026, 23(1): 15-20
Perspective | Open Access
Beyond origin: multimodal AI synthesis to resolve cancers of unknown primary
Published: 01 January 2026
2026, 23(1): 21-29
REVIEW
Review | Open Access
Innovative cross-intervention: copper ions and metabolic pathways in cancer therapy
Published: 20 January 2026
2026, 23(1): 30-41
Review | Open Access
CD4+ T cells in cancer: dual roles, exhaustion, and therapeutic breakthroughs
Published: 01 January 2026
2026, 23(1): 42-59
Review | Open Access
Gut microecology empowers cancer immunotherapy: commensal microbiota-mediated mechanisms and translational prospects of PD-1/PD-L1 therapy
Published: 29 January 2026
2026, 23(1): 60-77
LETTER
Letter | Open Access
Impact of pre-neoadjuvant radioactive iodine seed marking on pathologic complete response and survival in early-stage breast cancer patients
Published: 26 December 2025
2026, 23(1): 78-85
ORIGINAL ARTICLE
Original Article | Open Access
Migration and invasion inhibitory protein inhibits M2 macrophage polarization to suppress colorectal cancer progression through the STING–NFκB2–IL10 axis
Published: 14 January 2026
2026, 23(1): 86-106
Original Article | Open Access
Coordinated DNA methyltransferase 3A and methyltransferase-like 7A activity reprograms the tumor microenvironment through discoidin domain receptor 1 signaling
Published: 01 January 2026
2026, 23(1): 107-132
Original Article | Open Access
Antitumor effects of STING agonists on nervous system tumors via tumor-intrinsic STING-STAT1-mediated HMGN2 expression
Published: 01 January 2026
2026, 23(1): 133-153